Johnson & Johnson is a global healthcare company with a diversified portfolio of pharmaceutical and medical products
About the company
The company requested a comprehensive legal and regulatory overview of domestic and international circulation of medicinal products. Within three years, we provided expert support on regulatory matters related to the circulation of medicines containing narcotic and psychotropic substances, as well as on HIV prevention and treatment policies.
Client’s request
Our results:
Timely adjustments made to client’s strategy.
01
Minimized regulatory risks.
02
Our solution
Key focus areas
01
- In 2018, we conducted a comparative legal analysis of regulatory acts in Russia, the EAEU countries, the US, Canada, and the EU.
Comparative Legal Studies
03
- In 2020, we provided analytical and GR support to address risks arising from changes in pharmaceutical supply regulation and evolving approaches to the treatment of socially significant diseases.
Analytical and GR support
02
- In 2019, we completed an audit of key stakeholder opinions to forecast the implementation of Russia’s HIV policy for 2020–2025.
Stakeholder Opinion Audit
© 2015 — 2026 Baikal Lobridge.
All rights reserved.
All rights reserved.
ООО «БКГ»
ОГРН 1157746465667 | ИНН 7727176391 | КПП 770301001
123056, Россия, г. Москва, ул. Большая Грузинская 30А, стр. 1, БЦ «Грузинка 30»
ОГРН 1157746465667 | ИНН 7727176391 | КПП 770301001
123056, Россия, г. Москва, ул. Большая Грузинская 30А, стр. 1, БЦ «Грузинка 30»
Submit a request and our specialists will contact you for all the details.
Contact Baikal Lobridge®
Submit a request and our specialists will contact you for all the details.
Contact Baikal Lobridge®
